exciting potential of pembrolizumab combined with axitinib for kidney cancer
Published 5 years ago • 261 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
3:30
promising results for axitinib and pembrolizumab in advanced renal cell cancer
-
2:31
axitinib plus pembrolizumab in advanced rcc
-
5:10
real-world treatment outcomes of 1l axitinib pembrolizumab in patients with advanced rcc in the us
-
1:00
pembrolizumab/axitinib and avelumab/axitinib combo for rcc
-
0:49
clear: lenvatinib and pembrolizumab in advanced renal cell carcinoma
-
2:18
pembrolizumab monotherapy and pembro-axitinib for rcc
-
4:47
keynote-426 - pembrolizumab plus axitinib versus sunitinib for mrcc
-
2:31
recent immunotherapy advances in rcc
-
4:25
kidney cancer updates: avelumab/axitinib, pembro/axitinib, bevacizumab/atezo & ipilimumab/nivo
-
0:59
combining lenvatinib & pembrolizumab for non-clear cell rcc: keynote-b61 study rationale
-
5:16
potential new treatments in renal cell carcinoma
-
1:19
dr. rini on the efficacy of axitinib and pembrolizumab in rcc
-
1:31
combining immunotherapy with vegf inhibitors to treat kidney cancer
-
2:16
treating kidney cancer with axitinib &avelumab, or axitinib & pembrolizumab?
-
1:44
assessing lenvatinib with pembrolizumab in advanced renal cell carcinoma
-
1:03
potential of adjuvant therapy for rcc
-
1:56
dr. cost on pembrolizumab plus axitinib in patients with rcc
-
1:03
dr. rini on managing the toxicity of pembrolizumab plus axitinib in mrcc
-
1:04
dr. rini discusses pembrolizumab plus axitinib in mrcc